BIONTECH SE SPON ADS EACH REP 1 ORD SHS (BNTX) - Price, trends, fundamentals and chart - Passport to Wall Street

BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ: BNTX)

Overview

current price

$94.95

$94.95

change

-0.45 | -0.47%

-0.45 | -0.47%

Yesterday's Close

95.40

open

95.84

volume

0.62 M

30d. avg volume.

0.88 M

1 day

93.72 - 96.01

52 weeks

76.53 - 131.49

p/e

0.00

beta

0.2865

market cap

22.89 B

dividend yield

0.00%

Industry

-

News and Commentary

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows Moderna Inc. (MRNA&nbs...

UK, Taiwan Approve Moderna's Updated COVID-19 Shot On Tuesday, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Moderna, Inc.'s

Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program Starting in late September, U.S. households can order up to four COVID-19 nasal swab tests when the federal program reopens.The exact date for ordering...

FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to...

Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study On Friday, Pfizer Inc. (PFE

BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D S... Monday, BioNTech SE (BNTX

GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5... Wednesday, GSK plc (GSK...

London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents Pfizer Inc. (PFE

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment AstraZeneca PLC (AZN&nb...

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season On Friday, Moderna Inc. (MRNA...

StockTwits

StockTwits